We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VIRX market cap is 22.86M. The company's latest EPS is USD -1.3001 and P/E is -0.46.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.21M | -12.45M | -12.48M | -13.56M | -13.88M |
| Net Income | -12.21M | -12.48M | -12.6M | -13.77M | -9.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.07M | 120k | 13.5M | 0 | 0 |
| Operating Income | -23.29M | -22.3M | -114.28M | -50.59M | -50.69M |
| Net Income | -23.33M | -21.61M | -114.76M | -49.2M | -51.06M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 85.78M | 76.86M | 66.44M | 56.69M | 41.33M |
| Total Liabilities | 34.67M | 36.08M | 36.43M | 38.37M | 30.25M |
| Total Equity | 51.11M | 40.78M | 30.01M | 18.32M | 11.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 37.24M | 23.25M | 108.55M | 95.99M | 56.69M |
| Total Liabilities | 9.7M | 3.31M | 14.18M | 34.89M | 38.37M |
| Total Equity | 27.54M | 19.94M | 94.37M | 61.1M | 18.32M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.34M | -19.33M | -29.87M | -39.89M | -7.85M |
| Investing | -7.35M | -3.37M | 5.73M | 15M | 14.19M |
| Financing | 16k | 220k | 220k | 438k | -6.6M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.19M | -21.44M | -18.85M | -35.46M | -39.89M |
| Investing | -16.29M | 16.41M | 12.89M | -53.87M | 15M |
| Financing | 43.04M | 7.18M | 62.43M | 22.54M | 438k |
| Market Cap | 22.86M |
| Price to Earnings Ratio | -0.46 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.91 |
| Price to Book Ratio | 1.29 |
| Dividend Yield | - |
| Shares Outstanding | 39.27M |
| Average Volume (1 week) | 141.13k |
| Average Volume (1 Month) | 124.33k |
| 52 Week Change | -61.70% |
| 52 Week High | 1.68 |
| 52 Week Low | 0.43 |
| Spread (Intraday) | 0.04 (6.85%) |
| Company Name | Viracta Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.viracta.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
